A director at Tele2 AB bought 4,500 shares at 101.150SEK and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress Media ReleaseCOPENHAGEN, Denmark; May 14, 2024 Sixteen abstracts accepted for presentation and publication demonstrate depth and breadth of comprehensive epcoritamab development programThree oral presentations highlight novel data evaluating epcoritamab in patients with relapsed/refractory (R/R) follicular lymphoma (FL), in combination for first-line treatment of diffuse large B-cell lymphoma (DLBCL),...
Yesterday we attended Royal Unibrew’s CMD in the Netherlands. We found the event informative, especially about recent years’ acquisitions in Norway and the Netherlands. Our impression was that momentum is strong, and that the recent long-term organic EBIT target of 6–8% growth could be conservative. Following years of headwinds, the company seems to be emerging in a stronger position than ever. We reiterate our BUY and DKK625 target price.
A director at Carlsberg AS sold 13,517 shares at 941.660DKK and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
Transactions in Connection with Share Buy-back Program Company Announcement COPENHAGEN, Denmark; May 13, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares.The share buy-back program is expected to be completed no later than December 16, 2024. The following transactions were executed under the program from May 6, 2024 to May 10, 2024: Trading PlatformNo. of sharesAverage price (DKK)Total value (DKK)Accumulated through last announcement 689,510 1,393,154,997.08May 6, 2...
Launch of Long-Term Incentive Plan for executive management and key employees COMPANY ANNOUNCEMENT NO 14/2024 – MAY 13, 2024 Royal Unibrew A/S launches a new share based Long-Term Incentive Plan (LTIP) for selected key employees for 2024 designed to align the interests of Royal Unibrew’s employees and shareholders and to retain employees. The new LTIP for 2024 has been approved by the Board of Directors. The LTIP is based on Performance Share Units (PSU) granted to each key employee. The PSUs are granted in 2024 for vesting on the date the Board of Directors approves and makes public the ...
Transactions in connection with share buyback programme Company Announcement Copenhagen, 13 May 2024 No. 21/2024 Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility management company, announced on 22 February 2024 a new share buyback programme, see company announcement no. 4/2024. The share buyback programme is executed in accordance Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 ...
>Underperform recommendation, target price of NOK6 - Following the link-up with TGS, PGS shareholders will receive 0.06829 TGS shares for each PGS share held. We think this transaction makes sense for PGS shareholders, but we believe that it is more difficult to justify for shareholders of TGS shareholder whose business model of an asset-light group has proven its resilience over the past cycles. Following the Q1 2024 results publication and conference call, we maint...
>Recommandation Sous-performance OC 6 NOK - A l’issue du rapprochement avec TGS, les actionnaires de PGS recevront 0.06829 action TGS pour chaque action PGS. Nous pensons que cette opération fait du sens pour les actionnaires de PGS mais nous estimons qu’elle est plus difficile à justifier pour un actionnaire de TGS dont le business model d’un groupe asset light a fait la preuve de sa résilience aux cours des différents cycles passés. A l’issue de la publication et d...
Sweden’s Riksbank cut the policy rate this week to 3.75% (4.0%); our estimates are based on another four cuts by end-2025. During the week we upgraded Veidekke to BUY, downgraded Castellum to HOLD, and reiterated our HOLD on Kojamo and SELL on Hufvudstaden and Sagax. The average implied EBITDA yields on the stocks we cover are 4.40% for 2024e and 4.79% for 2025e.
PGS Contract Award in West Africa May 10, 2024, Oslo, Norway: PGS is awarded a 4D contract in West Africa for an international energy company. Mobilization is scheduled for early September. The contract has a total duration of approximately 65 days, with an option to extend. “We are very pleased with this contract award, securing visibility for another of our vessels well into the fourth quarter. After completion of scheduled acquisitions programs during the Northern Europe summer season we will steam a vessel to West Africa to commence this contract. By combining the Ramform acquisition p...
Q1 EBITDA was below expectations, on higher costs. While cash conversion appeared exceptionally strong, we believe it was driven by non-recurring items, leaving underlying cash flow much weaker than headline figures suggest. We forecast negative underlying FCF in 2024, adjusting for arbitration proceeds received in Q1. Expecting soft vessel utilisation in Q2 as well, due to steaming and yard stays, we have reduced our 2024e EBITDA by 7%. We reiterate our HOLD, but have cut our target price to NO...
PGS ASA: First Quarter 2024 Results Good start to 2024 Highlights Q1 2024 Produced Revenues of $222.6 million, compared to $172.2 million in Q1 2023Produced EBITDA of $112.5 million, compared to $71.5 million in Q1 2023Produced EBIT (ex. Impairments and other charges, net) of $26.1 million, compared to a loss of $19.7 million in Q1 2023Revenues and Other Income according to IFRS of $217.2 million, compared to $143.1 million in Q1 2023Cash flow from operations of $127.8 million, compared to $134.4 million in Q1 2023Cash and cash equivalents of $147.2 million, compared to $154.1 millio...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.